Physician profile
William Berglind
NPI 1518228741
$3,943.15
in general payments reported to CMS, 2019-2025
15 companies · $1,822 in 2025
The $1,822 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $17.21 · 2021: $1,219 · 2022: $80.08 · 2023: $139 · 2024: $462 · 2025: $1,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360 · Travel and Lodging: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.55 |
| Travel and Lodging | $1,063.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,485.79 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $1,251.00 | 2021-2024 | |
| Organogenesis INC. | $418.35 | 2019-2025 | Affinity, Puraply, Nushield |
| Baxter Healthcare | $139.50 | 2025 | Tisseel |
| Lilly USA, LLC | $113.40 | 2025 | Zepbound, Mounjaro |
| Conmed Corporation | $92.32 | 2024 | Airseal |
| Aroa Biosurgery Incorporated | $89.65 | 2023 | |
| Boston Scientific Corporation | $87.82 | 2024 | Axios |
| Takeda Pharmaceuticals U.S.A., INC. | $78.22 | 2024-2025 | Gattex |
| Vertex Pharmaceuticals Incorporated | $58.28 | 2024-2025 | |
| Novo Nordisk INC | $51.64 | 2022-2025 | Wegovy |
| Pacira Pharmaceuticals Incorporated | $28.32 | 2023 | Exparel |
| Acera Surgical, INC. | $19.96 | 2022 | |
| Next Science LLC | $17.90 | 2019 | |
| Advanced Oxygen Therapy INC. | $11.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Berglind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.